A CASE STUDY OF BUINESS ETHICS MANAGEMENT
AT CIPLA LTD.
Submitted by –
Roll no. – 21/055
Apeejay School of Management
Cipla Limited is a pharmaceutical company based in Mumbai, India. Founded by nationalist Indian scientist Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories in 1935. Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions. Founded prior to Indian independence and on the principle that India needed to become self-sufficient in supplying medicine to its people, Cipla has emphasized self-reliance and the right of all people to health and access to medicine, regardless of their economic circumstances or where in the world they happen to live. Cipla cooperates with other enterprises in areas such as consulting, commissioning, engineering, project appraisal, quality control, know-how transfer, support, and plant supply.
* One of the world’s largest generic companies.
* Over 2,000 products, 65 therapeutic categories, over 40 dosage forms.
* 34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.
* Continuous innovation in R&D; over 20 world firsts.
Cipla’s journey began in 1935 when our founder, Dr. K. A. Hamied, set up an enterprise with the vision to make India self-sufficient in healthcare. Over the past 77 years, they have emerged as one of the world’s most respected pharmaceutical names, not just in India but worldwide.
They have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies. They have over 2000 products in 65 therapeutic categories; with over 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases.
Research and Development (R&D) centre is focused on developing innovative products and drug delivery systems, giving the country and the world many ‘Firsts'.
Today, they are one of the world’s largest generic pharmaceutical companies with a strong presence in over 170 countries. They maintain world-class quality across all products and services.
* In 1935, the founder, Dr. K. A. Hamied set up Cipla to make India self-reliant in healthcare.
* In 1939, Mahatma Gandhi visited Cipla and inspired the founder to make essential medicines for the country, and strive for self-sufficiency. During World War II, when India was dependent on imported medicines and there was an alarming shortage of life-saving drugs, we manufactured them for the country.
* In the 1960s, they pioneered API manufacturing in the country and helped lay the foundation for the bulk drug industry in India.
* In 1970, they spearheaded the New Patent Law by which an Indian pharmaceutical company was allowed to manufacture a patented product as long as the process to manufacture it was changed. This enabled Indian companies for the first time to manufacture any medicines and make them available and affordable for all Indians.
* In 1978, they pioneered inhalation therapy in India with the manufacture of Metered-Dose Inhaler (MDI), at a time when the country stopped receiving imported supplies. Today, we have the world’s largest range of inhaled medication and devices.
* In 1994, they launched Deferiprone, the world’s first oral iron chelator which revolutionized the treatment for thalassemia. For the first time patients with thalassemia had an option that was affordable, painless and convenient.
* In 1996, they gave the world the first transparent dry powder inhaler which was so simple and easy to use, it changed the face of inhalation therapy in India.
* In 2001, they pioneered the access to HIV treatment by...
References: * http://en.wikipedia.org/wiki/Cipla
Please join StudyMode to read the full document